Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin plus emotion recognition training in residential male youth with antisocial behavior
NL-OMON49988Phase 2Completed
- Sponsor
- Radboud University
- Start
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in antisocial personality disorder (ASPD) and externalizing disorders comparing Oxytocin + emotion recognition training with Placebo + emotion recognition training (2 arms). Primary endpoint: Change in emotion recognition skills. Started Dec 2020; status: completed.
02
Drugs
oxytocin
03
Conditions
antisocial personality disorder (ASPD)externalizing disorders
Beyond the preview
Go deeper on NL-OMON49988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49988.